NASDAQ : ICU
SeaStar Medical Holding Corporation — Key statistics
Healthcare · Biotechnology · United States
Last price 2.31 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 12.15M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 11.78M |
| Enterprise Value | 4.96M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 5.26M |
| Shares Outstanding | 5.26M |
| Shares Change (YoY) | +393.33% |
| Shares Change (QoQ) | +4.24% |
| Owned by Insiders (%) | 0.87% |
| Owned by Institutions (%) | 3.79% |
| Float | 5.21M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.88 |
| Forward PS | 11.78 |
| PB Ratio | 2.22 |
| P/TBV Ratio | 2.74 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 2.90 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.89 |
| Quick Ratio | 1.65 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -518.11 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -356.87% |
| Return on Assets (ROA) | -102.67% |
| Return on Invested Capital (ROIC) | -225.02% |
| Return on Capital Employed (ROCE) | -325.63% |
| Weighted Average Cost of Capital (WACC) | -1.30% |
| Revenue Per Employee | $95,167 |
| Profits Per Employee | -$757,056 |
| Employee Count | 18 |
| Asset Turnover | 0.20 |
| Inventory Turnover | 1.64 |
Taxes
| Measure | Value |
|---|
| Income Tax | 3,000 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | -1.04 |
| 52-Week Price Change | -60.69% |
| 50-Day Moving Average | 3.20 |
| 200-Day Moving Average | 3.33 |
| Relative Strength Index (RSI) | 35.38 |
| Average Volume (20 Days) | 249,873 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 185,839 |
| Short Previous Month | 143,724 |
| Short % of Shares Out | 3.53% |
| Short % of Float | 3.56% |
| Short Ratio (days to cover) | 0.93 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 1.71M |
| Gross Profit | 1.59M |
| Operating Income | -13.99M |
| Pretax Income | -13.62M |
| Net Income | -13.63M |
| EBITDA | n/a |
| EBIT | -13.99M |
| Loss Per Share | -$3.81 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 6.96M |
| Total Debt | 134,000 |
| Net Cash | 6.83M |
| Net Cash Per Share | $1.30 |
| Equity (Book Value) | 4.30M |
| Book Value Per Share | 1.01 |
| Working Capital | 3.88M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -13.69M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | 120,000 |
| Free Cash Flow | -13.69M |
| FCF Per Share | -$2.60 |
Margins
| Measure | Value |
|---|
| Gross Margin | 92.64% |
| Operating Margin | -816.64% |
| Pretax Margin | -795.33% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -393.33% |
| Shareholder Yield | n/a |
| Earnings Yield | -170.17% |
| FCF Yield | -116.20% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $10.00 |
| Price Target Difference | 346.43% |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 134.93% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Jan 5, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -28.31 |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |